IP Library Granted Patent US 9,453,219
Granted Patent B2
US 9,453,219 · App. 12/003,662 · Granted Sep 27, 2016

Cosmetic designs and products using intronic RNA

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,453,219
App. No.
12/003,662
Granted
Sep 27, 2016
Kind
B2
Abstract

The present invention relates to a method and composition for generating a non-naturally occurring intron and its components capable of being processed into small hairpin RNA (shRNA) and/or microRNA (miRNA) molecules by skin cells and thus inducing specific gene silencing effects on skin pigment-related genes and/or aging-causing genes in the cells. The gene silencing effects so obtained are not only useful for lightening and whitening skin colors but also useful for suppressing unwanted aging gene activities in skins.

Claims (12)

1. An isolated nucleic acid composition for inducing microRNA mir-434-associated gene silencing effects against tyrosinase, comprising:

a SpRNAi-RGFP expression vector capable of expressing an intronic RNA molecule having a sequence which contains the sequence of SEQ.ID.NO:8, wherein the intronic RNA molecule having the sequence of SEQ.ID.NO.8 targets tyrosinase gene.

2. The isolated nucleic acid composition as defined in claim 1 , wherein said intronic RNA molecule contains a sequence which contains the sequence of SEQ ID NO:9 for inducing gene silencing against tyrosinase and is processed into a mature microRNA having the sequence of SEQ.ID.NO.9.

3. The isolated nucleic acid composition as defined in claim 1 , wherein said intronic RNA molecule contains a hairpin stem-loop structure.

4. The isolated nucleic acid composition as defined in claim 3 , wherein said hairpin stem-loop structure contains a sequence which contains the sequence of either SEQ ID NO:1 or the sequence of SEQ ID NO:2 for inducing gene silencing against tyrosinase.

5. The isolated nucleic acid composition as defined in claim 1 , which is a nucleic acid template encoding said intronic RNA molecule.

6. The isolated nucleic acid composition as defined in claim 1 , further containing a 5′-donor splice site, a 3′-acceptor splice site, and a branch point motif.

7. The isolated nucleic acid composition as defined in claim 1 , further containing sequences which contains the sequence of SEQ.ID.NO:3, the sequence of SEQ.ID.NO:4, and the sequence of SEQ.ID.NO:5.

8. The isolated nucleic acid composition as defined in claim 1 , further containing a recombinant mir-434-5p pre-miRNA insert having the sequence of SEQ.ID.NO:25.

9. The isolated nucleic acid composition as defined in claim 1 , which can be delivered into cells for expression.

10. The isolated nucleic acid composition as defined in claim 9 , which can be delivered into cells by vector transfection.

11. The isolated nucleic acid composition as defined in claim 10 , wherein said vector is a plasmid or its derivative.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2008
From: WU, DAVID TS; LIN, SHI-LUNG
To: MELLO BIOTECH TAIWAN CO., LTD.
Reel/Frame 020735/0605 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2008
From: MELLO BIOTECH TAIWAN CO., LTD.
To: WU, DAVID TS; LIN, SHI-LUNG
Reel/Frame 020729/0597 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2007
From: LIN, SHI-LUNG; WU, DAVID TS
To: MELLO BIOTECH TAIWAN CO., LTD.
Reel/Frame 020351/0328 →